Clinical trial
A Randomized, Double Blind Placebo Controlled Phase 1 Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ZYGK1, a Novel Glucokinase Activator, Following Oral Administration in Healthy Volunteers
NCT01472809 is registered in ClinicalTrials.gov with Zydus Lifesciences Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double Blind Placebo Controlled Phase 1 Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ZYGK1, a Novel Glucokinase Activator, Following Oral Administration in Healthy Volunteers
- Lead sponsor
- Zydus Lifesciences Limited
- Phase
- Phase 1
- Overall status
- Suspended
- Start date
- December 31, 2011
- Completion date
- Not reported
- Enrollment
- 96 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes